• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管主动脉瓣置换术后持续性二尖瓣反流患者的预后。

Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.

机构信息

Department of Cardiology, Heart Center, University of Cologne, Kerpener Str. 61, 50937, Cologne, Germany.

Department of Cardiothoracic Surgery, Heart Center, University of Cologne, Cologne, Germany.

出版信息

Clin Res Cardiol. 2020 Oct;109(10):1261-1270. doi: 10.1007/s00392-020-01618-9. Epub 2020 Feb 18.

DOI:10.1007/s00392-020-01618-9
PMID:32072263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7515951/
Abstract

OBJECTIVE

The objective of this study was to assess imaging predictors of mitral regurgitation (MR) improvement and to evaluate the impact of MR regression on long-term outcome in patients undergoing transcatheter aortic valve replacement (TAVR).

BACKGROUND

Concomitant MR is a frequent finding in patients with severe aortic stenosis but usually left untreated at the time of TAVR.

METHODS

Mitral regurgitation was graded by transthoracic echocardiography before and after TAVR in 677 consecutive patients with severe aortic stenosis. 2-year mortality was related to the degree of baseline and discharge MR. Morphological echo analysis was performed to determine predictors of MR improvement.

RESULTS

15.2% of patients presented with baseline MR ≥ 3 +, which was associated with a significantly decreased 2-year survival (57.7% vs. 74.4%, P < 0.001). MR improved in 50% of patients following TAVR, with 44% regressing to MR ≤ 2 +. MR improvement to ≤ 2 + was associated with significantly better survival compared to patients with persistent MR ≥ 3 +. Baseline parameters including non-severe baseline MR, the extent of mitral annular calcification and large annular dimension (≥ 32 mm) predicted the likelihood of an improvement to MR ≤ 2 +. A score based on these parameters selected groups with differing probability of MR ≤ 2 + post TAVR ranging from 10.5 to 94.4% (AUC 0.816; P < 0.001), and was predictive for 2-year mortality.

CONCLUSION

Unresolved severe MR is a critical determinant of long term mortality following TAVR. Persistence of severe MR following TAVR can be predicted using selected parameters derived from TTE-imaging. These data call for close follow up and additional mitral valve treatment in this subgroup. Factors associated with MR persistence or regression after TAVR.

摘要

目的

本研究旨在评估经导管主动脉瓣置换术(TAVR)后二尖瓣反流(MR)改善的影像学预测因素,并评估 MR 消退对患者长期预后的影响。

背景

在严重主动脉瓣狭窄患者中,并发 MR 是一种常见发现,但在 TAVR 时通常不予治疗。

方法

对 677 例连续严重主动脉瓣狭窄患者行 TAVR 前后经胸超声心动图(TTE)评估 MR。2 年死亡率与基线和出院时 MR 程度相关。进行形态回声分析以确定 MR 改善的预测因素。

结果

15.2%的患者基线 MR≥3+,2 年生存率显著降低(57.7%比 74.4%,P<0.001)。TAVR 后 50%的患者 MR 得到改善,44%的患者 MR 减轻至≤2+。与持续 MR≥3+的患者相比,MR 改善至≤2+与生存率显著提高相关。基线参数包括非严重基线 MR、二尖瓣环钙化程度和大环形尺寸(≥32mm)预测了 MR 改善至≤2+的可能性。基于这些参数的评分选择了 TAVR 后 MR≤2+的概率不同的组,范围从 10.5%到 94.4%(AUC 0.816;P<0.001),并预测了 2 年死亡率。

结论

未解决的严重 MR 是 TAVR 后长期死亡率的关键决定因素。TAVR 后严重 MR 的持续存在可以使用从 TTE 成像中获得的选定参数来预测。这些数据呼吁在这一亚组中密切随访和额外的二尖瓣治疗。与 TAVR 后 MR 持续或消退相关的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/c00f7dbe5008/392_2020_1618_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/de3d110c6423/392_2020_1618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/5466f2c2c10d/392_2020_1618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/ae3d8a442017/392_2020_1618_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/f9c89a8d5a67/392_2020_1618_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/02029641237e/392_2020_1618_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/c00f7dbe5008/392_2020_1618_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/de3d110c6423/392_2020_1618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/5466f2c2c10d/392_2020_1618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/ae3d8a442017/392_2020_1618_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/f9c89a8d5a67/392_2020_1618_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/02029641237e/392_2020_1618_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d911/7515951/c00f7dbe5008/392_2020_1618_Fig6_HTML.jpg

相似文献

1
Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术后持续性二尖瓣反流患者的预后。
Clin Res Cardiol. 2020 Oct;109(10):1261-1270. doi: 10.1007/s00392-020-01618-9. Epub 2020 Feb 18.
2
Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential Management.经导管主动脉瓣置换术后二尖瓣反流:预后、影像学预测因素和潜在的处理方法。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1603-14. doi: 10.1016/j.jcin.2016.05.025.
3
Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术后二尖瓣反流的转归和长期预后意义。
Int J Cardiol. 2019 Aug 1;288:39-43. doi: 10.1016/j.ijcard.2019.03.048. Epub 2019 Mar 27.
4
Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.基线二尖瓣反流对经导管主动脉瓣置换术后短期和长期预后的影响。
Am Heart J. 2016 Aug;178:19-27. doi: 10.1016/j.ahj.2016.03.020. Epub 2016 Apr 19.
5
Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.经导管主动脉瓣置换术治疗低流量低梯度主动脉瓣狭窄患者的二尖瓣反流:TOPAS-TAVI 注册研究的见解。
JACC Cardiovasc Interv. 2020 Mar 9;13(5):567-579. doi: 10.1016/j.jcin.2019.11.042. Epub 2020 Feb 12.
6
Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement.二尖瓣反流严重程度的变化会影响经导管主动脉瓣置换术后的生存。
Int J Cardiol. 2019 Nov 1;294:32-36. doi: 10.1016/j.ijcard.2019.07.075. Epub 2019 Jul 24.
7
Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术患者二尖瓣反流的二维超声心动图综合评估方法
Int J Cardiovasc Imaging. 2018 Aug;34(8):1193-1204. doi: 10.1007/s10554-018-1328-y. Epub 2018 Mar 10.
8
The Relationship of Mitral Annulus Shape at CT to Mitral Regurgitation after Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后 CT 测量二尖瓣环形态与二尖瓣反流的关系。
Radiology. 2021 Oct;301(1):93-102. doi: 10.1148/radiol.2021210267. Epub 2021 Jul 27.
9
CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome.经导管主动脉瓣置换术(TAVR)后二尖瓣反流变化的心脏磁共振成像(CMR)定量分析:对左心室逆向重构及预后的影响
Int J Cardiovasc Imaging. 2019 Jan;35(1):161-170. doi: 10.1007/s10554-018-1441-y. Epub 2018 Sep 4.
10
Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality.经导管主动脉瓣置换术对合并二尖瓣反流的影响及其对死亡率的影响。
JACC Cardiovasc Interv. 2021 Jun 14;14(11):1181-1192. doi: 10.1016/j.jcin.2021.02.030. Epub 2021 May 12.

引用本文的文献

1
Transcatheter Aortic Valve Implantation Indications and Patient Selection.经导管主动脉瓣植入术的适应症及患者选择
Interv Cardiol. 2025 Jun 10;20:e19. doi: 10.15420/icr.2024.44. eCollection 2025.
2
Risk factors and predictive models for post-operative moderate-to-severe mitral regurgitation following transcatheter aortic valve replacement: a machine learning approach.经导管主动脉瓣置换术后发生中重度二尖瓣反流的危险因素及预测模型:一种机器学习方法
BMC Cardiovasc Disord. 2025 May 10;25(1):361. doi: 10.1186/s12872-025-04759-9.
3
Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation.

本文引用的文献

1
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
2
Clinical impact of post procedural mitral regurgitation after transcatheter aortic valve replacement.经导管主动脉瓣置换术后二尖瓣反流的临床影响。
Int J Cardiol. 2020 Jan 15;299:215-221. doi: 10.1016/j.ijcard.2019.07.092. Epub 2019 Aug 1.
3
经导管主动脉瓣植入术后未经治疗的中度二尖瓣反流的演变
Medicina (Kaunas). 2025 Apr 9;61(4):686. doi: 10.3390/medicina61040686.
4
Mixed-Valve Disease: Management of Patients with Aortic Stenosis and Mitral Regurgitation: Thresholds for Surgery Versus Percutaneous Therapies.混合瓣膜病:主动脉瓣狭窄合并二尖瓣反流患者的管理:手术与经皮治疗的阈值
US Cardiol. 2021 Nov 29;15:e26. doi: 10.15420/usc.2021.17. eCollection 2021.
5
Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses.病例报告:经导管同期主动脉瓣和二尖瓣置换术治疗有症状的主动脉瓣和二尖瓣联合狭窄。
Front Cardiovasc Med. 2024 Dec 9;11:1487061. doi: 10.3389/fcvm.2024.1487061. eCollection 2024.
6
The impact of transcatheter aortic valve implantation (TAVI) on mitral regurgitation - a single center study.经导管主动脉瓣植入术(TAVI)对二尖瓣反流的影响——一项单中心研究
Cardiol J. 2024;31(6):833-842. doi: 10.5603/cj.98792. Epub 2024 Aug 7.
7
Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls.用于主动脉瓣狭窄终身管理的生物人工瓣膜:要点与陷阱
J Clin Med. 2023 Nov 13;12(22):7063. doi: 10.3390/jcm12227063.
8
Prognostic Impact of Residual Moderate Mitral Regurgitation Following Valve-in-Valve Transcatheter Aortic Valve Implantation.经导管主动脉瓣置换术后残余中度二尖瓣反流的预后影响。
Braz J Cardiovasc Surg. 2023 Oct 27;39(1):e20230012. doi: 10.21470/1678-9741-2023-0012.
9
Transcatheter mitral valve implantation using the Tendyne valve in a patient with prior transcatheter aortic valve implantation: a case report.在一位曾接受经导管主动脉瓣植入术的患者中使用Tendyne瓣膜进行经导管二尖瓣植入:病例报告
Eur Heart J Case Rep. 2023 Sep 29;7(10):ytad476. doi: 10.1093/ehjcr/ytad476. eCollection 2023 Oct.
10
Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis.经导管主动脉瓣置换术前后重度低流量、低梯度主动脉瓣狭窄患者二尖瓣反流对预后的影响。
J Am Heart Assoc. 2023 Sep 5;12(17):e029553. doi: 10.1161/JAHA.123.029553. Epub 2023 Aug 30.
Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement.
二尖瓣反流严重程度的变化会影响经导管主动脉瓣置换术后的生存。
Int J Cardiol. 2019 Nov 1;294:32-36. doi: 10.1016/j.ijcard.2019.07.075. Epub 2019 Jul 24.
4
Transvascular transcatheter aortic valve implantation in 2017.2017 年经导管主动脉瓣置入术。
Clin Res Cardiol. 2020 Mar;109(3):303-314. doi: 10.1007/s00392-019-01509-8. Epub 2019 Jun 24.
5
Significant mitral regurgitation in patients undergoing TAVR: Mechanisms and imaging variables associated with improvement.经导管主动脉瓣置换术患者的严重二尖瓣反流:与改善相关的机制和影像学变量
Echocardiography. 2019 Apr;36(4):722-731. doi: 10.1111/echo.14303. Epub 2019 Mar 4.
6
Outcome and undertreatment of mitral regurgitation: a community cohort study.二尖瓣反流的结局和治疗不足:社区队列研究。
Lancet. 2018 Mar 10;391(10124):960-969. doi: 10.1016/S0140-6736(18)30473-2.
7
The 'Ten Commandments' in Valvular Heart Disease Guidelines.心脏瓣膜病指南中的“十诫”。
Eur Heart J. 2017 Sep 21;38(36):2699. doi: 10.1093/eurheartj/ehx471.
8
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.原发性瓣膜反流的非侵入性评估建议:美国超声心动图学会与心血管磁共振学会合作制定的报告
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371. doi: 10.1016/j.echo.2017.01.007. Epub 2017 Mar 14.
9
In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany.2014 年德国常规孤立手术或经股动脉经导管主动脉瓣置换术低危患者的院内死亡率。
Clin Res Cardiol. 2017 Aug;106(8):610-617. doi: 10.1007/s00392-017-1097-y. Epub 2017 Mar 10.
10
Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.同期二尖瓣环钙化和重度主动脉瓣狭窄经导管主动脉瓣置换术后的患病率、特征和结局。
Eur Heart J. 2017 Apr 21;38(16):1194-1203. doi: 10.1093/eurheartj/ehw594.